RT Journal Article
SR Electronic
T1 Use of urokinase in the treatment of tuberculous meningitis hydrocephalus
JF Neurosciences Journal
JO Neurosciences (Riyadh)
FD Prince Sultan Military Medical City
SP 75
OP 77
VO 14
IS 1
A1 Abuhamed, Mutasem M.
A1 Zhi, Song
A1 Bo, Xiao
YR 2009
UL http://nsj.org.sa/content/14/1/75.abstract
AB We present a patient with hydrocephalus after tuberculous meningitis successfully treated with urokinase. She presented with multiple episodes of headache, fever, and vomiting. She underwent external ventricular drainage and was treated with urokinase in addition to dexamethasone, acetazolamide, and 4 antituberculous drugs. She was evaluated clinically, radiologically, and by laboratory work-up. On short-term clinical follow-up (3 months), she was asymptomatic after the treatment with urokinase. She was radiologically evaluated 3 weeks after the treatment. An MRI of the brain showed a decrease in ventricular size. Urokinase can be considered as a safe and promising adjunctive treatment for tuberculous meningitis hydrocephalus.